Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Excitatory and Inhibitory Effects of Neurotransmitters01:29

Excitatory and Inhibitory Effects of Neurotransmitters

14.4K
When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of...
14.4K
Neural Regulation01:37

Neural Regulation

44.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
44.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differential cerebral white matter tract alterations in generalized anxiety disorder revealed by ultra-high-field 7 T diffusion-weighted imaging.

Journal of affective disorders·2026
Same author

Effects of chemogenetic inhibition of serotonergic raphe-striatal neurons on L-DOPA-induced behaviors and neurochemistry in a rat model of Parkinson's disease.

Acta neuropathologica communications·2026
Same author

Dopaminergic Modulation of Striatal Somatostatin Interneurons Shapes Motor Learning and L-DOPA-Induced Dyskinesia.

Molecular neurobiology·2026
Same author

Premature release of action sequences in adolescent male rats.

Frontiers in behavioral neuroscience·2026
Same author

Artificial microRNAs targeting tau enable post-symptomatic functional recovery in aged tauopathy mice.

Molecular therapy. Nucleic acids·2026
Same author

Differential Cerebral White Matter Tract Alterations in Generalized Anxiety Disorder Revealed by Ultra-High Field 7T Diffusion-Weighted Imaging.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Mar 15, 2026

Profiling Voltage-gated Potassium Channel mRNA Expression in Nigral Neurons using Single-cell RT-PCR Techniques
07:31

Profiling Voltage-gated Potassium Channel mRNA Expression in Nigral Neurons using Single-cell RT-PCR Techniques

Published on: September 27, 2011

15.6K

Decrease of a Current Mediated by Kv1.3 Channels Causes Striatal Cholinergic Interneuron Hyperexcitability in

Cecilia Tubert1, Irene R E Taravini2, Eden Flores-Barrera3

  • 1IFIBIO Bernardo Houssay, Grupo de Neurociencia de Sistemas, Facultad de Medicina, Universidad de Buenos Aires - CONICET, 2155 Paraguay Street, Buenos Aires 1121, Argentina.

Cell Reports
|August 30, 2016
PubMed
Summary
This summary is machine-generated.

Parkinson's disease (PD) involves a hypercholinergic state due to impaired Kv1 channel function. Targeting Kv1.3 channels may offer new therapeutic strategies for PD by restoring normal neuronal activity.

More Related Videos

Primary Culture of Mouse Dopaminergic Neurons
11:58

Primary Culture of Mouse Dopaminergic Neurons

Published on: September 8, 2014

39.7K
Development of a Unilaterally-lesioned 6-OHDA Mouse Model of Parkinson's Disease
10:09

Development of a Unilaterally-lesioned 6-OHDA Mouse Model of Parkinson's Disease

Published on: February 14, 2012

52.4K

Related Experiment Videos

Last Updated: Mar 15, 2026

Profiling Voltage-gated Potassium Channel mRNA Expression in Nigral Neurons using Single-cell RT-PCR Techniques
07:31

Profiling Voltage-gated Potassium Channel mRNA Expression in Nigral Neurons using Single-cell RT-PCR Techniques

Published on: September 27, 2011

15.6K
Primary Culture of Mouse Dopaminergic Neurons
11:58

Primary Culture of Mouse Dopaminergic Neurons

Published on: September 8, 2014

39.7K
Development of a Unilaterally-lesioned 6-OHDA Mouse Model of Parkinson's Disease
10:09

Development of a Unilaterally-lesioned 6-OHDA Mouse Model of Parkinson's Disease

Published on: February 14, 2012

52.4K

Area of Science:

  • Neuroscience
  • Neuropharmacology
  • Ion Channel Physiology

Background:

  • The exact cause of the hypercholinergic state in Parkinson's disease (PD) is not fully understood.
  • Cholinergic interneurons in the striatum play a crucial role in motor control and are implicated in PD pathophysiology.

Purpose of the Study:

  • To investigate the role of Kv1 channel function in the hyperexcitability of striatal cholinergic interneurons in a mouse model of PD.
  • To identify specific Kv1 channel subunits involved in regulating cholinergic interneuron activity.

Main Methods:

  • Utilized a mouse model of Parkinson's disease.
  • Investigated the function of Kv1 channels in striatal cholinergic interneurons.
  • Examined the contribution of Kv1.3 subunits to the IsAHP current.

Main Results:

  • Disruption of Kv1 channel function leads to hyperexcitability of striatal cholinergic interneurons in PD models.
  • Kv1.3 subunits are significant contributors to the IsAHP potassium current in these neurons.
  • The inhibitory control by Kv1.3-mediated current on cholinergic interneuron excitability is reduced in the parkinsonian striatum.

Conclusions:

  • Kv1.3-containing channels play a critical, previously unrecognized role in regulating the firing patterns of striatal cholinergic interneurons.
  • The diminished Kv1.3 current in PD suggests that targeting Kv1.3 subunits could be a potential therapeutic avenue for Parkinson's disease.